Getting at MYC through RAS.
Bachireddy
Pavan
P
Division of Medical Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Bendapudi
Pavan K
PK
Felsher
Dean W
DW
D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D005204:Farnesol / Q000031:analogs & derivatives* / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008954:Models, Biological; D009447:Neuroblastoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism*; D012459:Salicylates / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism*
D016271:Proto-Oncogene Proteins c-myc; D012459:Salicylates; C093323:farnesylthiosalicylic acid; D005204:Farnesol; D018631:ras Proteins